Kidney Disease Chronic clinical trials

Explore recruiting kidney disease chronic clinical trials.

Recruiting kidney disease chronic studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Disease Chronic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement: a randomized, placebo-controlled, double-blinded multicenter superiority study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

(21839) A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes.

Italy, France, Netherlands, Belgium, Spain, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Kidney Disease Chronic trials by city

Kidney Disease Chronic clinical trials

Recruiting kidney disease chronic studies right now

Patiromer and Diet/hrQoL in Chronic Dialysis

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

Also recruiting in Europe

THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open label, cluster randomized controlled, phase 3 trial

Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement: a randomized, placebo-controlled, double-blinded multicenter superiority study

(21839) A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes.

Kidney Disease Chronic trials by city

Other conditions